(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FMO1 mRNA] CTD PMID:31150632 (R,R,R)-alpha-tocopherol increases expression EXP 6480464 alpha-Tocopherol results in increased expression of FMO1 mRNA CTD PMID:16908007 1,1-dichloroethene decreases expression ISO Fmo1 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of FMO1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO Fmo1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of FMO1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA CTD PMID:17522070 more ... 1-naphthyl isothiocyanate decreases expression ISO Fmo1 (Mus musculus) 6480464 1-Naphthylisothiocyanate results in decreased expression of FMO1 mRNA CTD PMID:15913567 17alpha-ethynylestradiol affects expression ISO Fmo1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of FMO1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of FMO1 mRNA and Estradiol results in decreased expression of FMO1 protein CTD PMID:21966433 and PMID:24894866 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FMO1 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO Fmo1 (Mus musculus) 6480464 Estradiol results in decreased expression of FMO1 mRNA CTD PMID:14664709 17beta-estradiol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1 mRNA] and resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1] CTD PMID:24894866 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of FMO1 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FMO1 mRNA CTD PMID:16214954 and PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fmo1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FMO1 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMO1 mRNA CTD PMID:11752688 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FMO1 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Fmo1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of FMO1 mRNA CTD PMID:18765683 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Fmo1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of FMO1 mRNA CTD PMID:19933214 and PMID:28922406 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of FMO1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of FMO1 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:16984957 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Fmo1 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of FMO1 mRNA CTD PMID:25172293 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of FMO1 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO1 mRNA CTD PMID:16054899 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FMO1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of FMO1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of FMO1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO Fmo1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of FMO1 mRNA CTD PMID:18648102 4-aminophenol multiple interactions ISO FMO1 (Homo sapiens) 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol CTD PMID:20369854 4-fluoroaniline multiple interactions ISO FMO1 (Homo sapiens) 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-fluoroaniline CTD PMID:20369854 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of FMO1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of FMO1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FMO1 mRNA CTD PMID:30047161 Actein increases expression EXP 6480464 actein results in increased expression of FMO1 protein CTD PMID:29969672 aminoguanidine multiple interactions EXP 6480464 pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 mRNA] and pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 protein] CTD PMID:10462538 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of FMO1 mRNA CTD PMID:19483382 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of FMO1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FMO1 mRNA CTD PMID:16483693 amphibole asbestos decreases expression ISO FMO1 (Homo sapiens) 6480464 Asbestos and Amphibole results in decreased expression of FMO1 protein CTD PMID:20855422 Aroclor 1254 increases expression ISO FMO1 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of FMO1 mRNA CTD PMID:17851650 atazanavir sulfate decreases expression ISO FMO1 (Homo sapiens) 6480464 Atazanavir Sulfate results in decreased expression of FMO1 mRNA CTD PMID:32152650 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of FMO1 mRNA CTD PMID:19483382 benzo[a]pyrene increases expression ISO Fmo1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of FMO1 mRNA CTD PMID:19770486 benzo[a]pyrene decreases expression ISO FMO1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of FMO1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO FMO1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of FMO1 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA and AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FMO1 mRNA] CTD PMID:22228805 and PMID:27858113 benzo[a]pyrene decreases expression ISO Fmo1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FMO1 mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO FMO1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of FMO1 mRNA CTD PMID:17879257 benzo[b]fluoranthene decreases expression ISO Fmo1 (Mus musculus) 6480464 benzo(b)fluoranthene results in decreased expression of FMO1 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA CTD PMID:27858113 benzydamine multiple interactions ISO FMO1 (Homo sapiens) 6480464 Benzydamine inhibits the reaction [FMO1 protein results in increased chemical synthesis of clozapine N-oxide] CTD PMID:18809730 benzydamine increases oxidation ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased oxidation of Benzydamine CTD PMID:21435388 beta-naphthoflavone decreases expression ISO FMO1 (Homo sapiens) 6480464 beta-Naphthoflavone results in decreased expression of FMO1 mRNA CTD PMID:22258563 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of FMO1 mRNA CTD PMID:16648578 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FMO1 mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FMO1 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO Fmo1 (Mus musculus) 6480464 bisphenol A results in decreased expression of FMO1 mRNA CTD PMID:30951980 and PMID:33221593 bisphenol A affects methylation ISO Fmo1 (Mus musculus) 6480464 bisphenol A affects the methylation of FMO1 promoter CTD PMID:27334623 bisphenol A increases expression ISO FMO1 (Homo sapiens) 6480464 bisphenol A results in increased expression of FMO1 mRNA CTD PMID:27685785 bisphenol F multiple interactions ISO FMO1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA CTD PMID:28628672 bisphenol F decreases expression ISO Fmo1 (Mus musculus) 6480464 bisphenol F results in decreased expression of FMO1 mRNA CTD PMID:30951980 bromoacetate decreases expression ISO FMO1 (Homo sapiens) 6480464 bromoacetate results in decreased expression of FMO1 mRNA CTD PMID:19753638 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of FMO1 mRNA CTD PMID:15056800 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of FMO1 mRNA CTD PMID:25993096 carbon nanotube decreases expression ISO Fmo1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO FMO1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to FMO1 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA more ... CTD PMID:32152650 and PMID:33819548 chloroform decreases expression EXP 6480464 Chloroform results in decreased expression of FMO1 mRNA CTD PMID:17522070 chrysene multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA CTD PMID:27858113 clofibrate multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA] CTD PMID:17585979 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of FMO1 mRNA CTD PMID:19483382 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO1 mRNA CTD PMID:17602206 clozapine increases metabolic processing ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased metabolism of Clozapine CTD PMID:18809730 Clozapine N-oxide increases chemical synthesis ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased chemical synthesis of clozapine N-oxide CTD PMID:18809730 Clozapine N-oxide multiple interactions ISO FMO1 (Homo sapiens) 6480464 Benzydamine inhibits the reaction [FMO1 protein results in increased chemical synthesis of clozapine N-oxide] CTD PMID:18809730 copper atom multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of FMO1 mRNA CTD PMID:26033743 copper(0) multiple interactions EXP 6480464 [Copper co-treated with Dietary Sucrose] results in decreased expression of FMO1 mRNA CTD PMID:26033743 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of FMO1 mRNA CTD PMID:15755911 coumarin decreases expression EXP 6480464 coumarin results in decreased expression of FMO1 mRNA CTD PMID:18480146 crocidolite asbestos decreases expression ISO Fmo1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of FMO1 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FMO1 mRNA CTD PMID:26577399 and PMID:27523638 cyclosporin A decreases expression ISO Fmo1 (Mus musculus) 6480464 Cyclosporine results in decreased expression of FMO1 mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA CTD PMID:32152650 cyclosporin A decreases expression ISO FMO1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of FMO1 mRNA CTD PMID:27989131 and PMID:32152650 cytarabine decreases expression ISO FMO1 (Homo sapiens) 6480464 Cytarabine results in decreased expression of FMO1 mRNA CTD PMID:21198554 D-penicillamine increases expression ISO FMO1 (Homo sapiens) 6480464 Penicillamine results in increased expression of FMO1 mRNA CTD PMID:22843330 deoxycholic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA more ... CTD PMID:32152650 and PMID:33819548 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of FMO1 mRNA CTD PMID:15102944 dexamethasone multiple interactions ISO FMO1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA CTD PMID:28628672 dexamethasone increases expression ISO Fmo1 (Mus musculus) 6480464 Dexamethasone results in increased expression of FMO1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FMO1 mRNA CTD PMID:16054899 dextran sulfate multiple interactions ISO Fmo1 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMO1 mRNA CTD PMID:29950665 dibenz[a,h]anthracene affects expression ISO Fmo1 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of FMO1 mRNA CTD PMID:21266533 diethylstilbestrol increases expression ISO Fmo1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of FMO1 mRNA CTD PMID:15171707 diethylstilbestrol decreases expression ISO Fmo1 (Mus musculus) 6480464 Diethylstilbestrol results in decreased expression of FMO1 mRNA CTD PMID:16636312 dihydroxyacetone decreases expression ISO FMO1 (Homo sapiens) 6480464 Dihydroxyacetone results in decreased expression of FMO1 mRNA CTD PMID:32506039 dioxygen multiple interactions ISO Fmo1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FMO1 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO FMO1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression ISO Fmo1 (Mus musculus) 6480464 Endosulfan results in decreased expression of FMO1 mRNA CTD PMID:22515965 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FMO1 mRNA CTD PMID:29391264 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of FMO1 mRNA CTD PMID:17522070 ethanol increases expression EXP 6480464 Ethanol results in increased expression of FMO1 mRNA CTD PMID:16946407 ethanol affects expression ISO Fmo1 (Mus musculus) 6480464 Ethanol affects the expression of FMO1 mRNA CTD PMID:30319688 ethanol increases expression ISO Fmo1 (Mus musculus) 6480464 Ethanol results in increased expression of FMO1 mRNA CTD PMID:19167417 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA CTD PMID:18253720 fenthion increases oxidation ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased oxidation of Fenthion CTD PMID:14976351 fentin chloride increases expression EXP 6480464 triphenyltin chloride results in increased expression of FMO1 mRNA CTD PMID:37156404 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of FMO1 mRNA CTD PMID:24136188 folic acid decreases expression ISO Fmo1 (Mus musculus) 6480464 Folic Acid results in decreased expression of FMO1 mRNA CTD PMID:25629700 genistein decreases expression ISO Fmo1 (Mus musculus) 6480464 Genistein results in decreased expression of FMO1 mRNA CTD PMID:32186404 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of FMO1 mRNA CTD PMID:24136188 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of FMO1 mRNA CTD PMID:24915197 glycochenodeoxycholic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycocholic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA more ... CTD PMID:32152650 and PMID:33819548 glycodeoxycholic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA more ... CTD PMID:32152650 and PMID:33819548 glyphosate decreases expression ISO Fmo1 (Mus musculus) 6480464 Glyphosate results in decreased expression of FMO1 protein CTD PMID:36173347 glyphosate affects methylation EXP 6480464 Glyphosate affects the methylation of FMO1 gene CTD PMID:35440735 glyphosate decreases expression EXP 6480464 Glyphosate results in decreased expression of FMO1 mRNA CTD PMID:26302742 Heptachlor epoxide decreases expression ISO Fmo1 (Mus musculus) 6480464 Heptachlor Epoxide results in decreased expression of FMO1 mRNA CTD PMID:25270620 hydrogen peroxide decreases expression ISO FMO1 (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of FMO1 mRNA CTD PMID:12419474 indometacin multiple interactions ISO FMO1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FMO1 mRNA CTD PMID:28628672 isoprenaline increases expression ISO Fmo1 (Mus musculus) 6480464 Isoproterenol results in increased expression of FMO1 mRNA CTD PMID:20003209 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA and [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA CTD PMID:18544905 L-ascorbic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO1 mRNA CTD PMID:17639512 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of FMO1 mRNA CTD PMID:19483382 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of FMO1 mRNA and Lipopolysaccharides results in decreased expression of FMO1 protein CTD PMID:10462538 lipopolysaccharide multiple interactions EXP 6480464 pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 mRNA] and pimagedine inhibits the reaction [Lipopolysaccharides results in decreased expression of FMO1 protein] CTD PMID:10462538 lipopolysaccharide multiple interactions ISO FMO1 (Homo sapiens) 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA CTD PMID:22777745 maleic acid increases expression ISO FMO1 (Homo sapiens) 6480464 maleic acid results in increased expression of FMO1 mRNA CTD PMID:28392987 methimazole increases oxidation ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased oxidation of Methimazole CTD PMID:14976351 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of FMO1 mRNA CTD PMID:30047161 methimazole multiple interactions EXP 6480464 Methimazole inhibits the reaction [[[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol] CTD PMID:20369854 methiocarb multiple interactions ISO FMO1 (Homo sapiens) 6480464 [FMO1 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb increases metabolic processing ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased metabolism of Methiocarb CTD PMID:27665777 methiocarb-sulfoxide increases abundance ISO FMO1 (Homo sapiens) 6480464 FMO1 protein results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methiocarb-sulfoxide multiple interactions ISO FMO1 (Homo sapiens) 6480464 [FMO1 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 methylmercury chloride decreases expression ISO FMO1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of FMO1 mRNA CTD PMID:23179753 monocrotaline multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA CTD PMID:21224054 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of FMO1 mRNA CTD PMID:21515302 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FMO1 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of FMO1 mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of FMO1 mRNA CTD PMID:17072980 and PMID:25380136 NADP zwitterion multiple interactions ISO FMO1 (Homo sapiens) 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol more ... CTD PMID:20369854 NADP zwitterion multiple interactions EXP 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol more ... CTD PMID:20369854 NADP(+) multiple interactions ISO FMO1 (Homo sapiens) 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of 4-aminophenol more ... CTD PMID:20369854 NADP(+) multiple interactions EXP 6480464 [[FMO1 protein co-treated with NADP] results in increased metabolism of 4-fluoro-N-methylaniline] which results in increased chemical synthesis of N-methyl-4-aminophenol more ... CTD PMID:20369854 nefazodone multiple interactions ISO FMO1 (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of FMO1 mRNA CTD PMID:32152650 nefazodone decreases expression ISO FMO1 (Homo sapiens) 6480464 nefazodone results in decreased expression of FMO1 mRNA CTD PMID:32152650 nevirapine decreases expression EXP 6480464 Nevirapine metabolite results in decreased expression of FMO1 mRNA CTD PMID:23947594 nickel atom decreases expression ISO FMO1 (Homo sapiens) 6480464 Nickel results in decreased expression of FMO1 mRNA CTD PMID:24768652 and PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of FMO1 mRNA CTD PMID:24136188 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of FMO1 mRNA CTD PMID:12102619 O-methyleugenol decreases expression ISO FMO1 (Homo sapiens) 6480464 methyleugenol results in decreased expression of FMO1 mRNA CTD PMID:32234424 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of FMO1 mRNA CTD PMID:19483382 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of FMO1 mRNA CTD PMID:23665939 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of FMO1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FMO1 mRNA CTD PMID:25729387 oxycodone affects expression EXP 6480464 Oxycodone affects the expression of FMO1 mRNA CTD PMID:20487198 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of FMO1 mRNA CTD PMID:23439660 ozone decreases expression ISO Fmo1 (Mus musculus) 6480464 Ozone results in decreased expression of FMO1 mRNA CTD PMID:12763052 ozone multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FMO1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FMO1 mRNA CTD PMID:34911549 paracetamol multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FMO1 mRNA] CTD PMID:17585979 paracetamol multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of FMO1 mRNA CTD PMID:33819548 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of FMO1 mRNA CTD PMID:17202762 more ... paracetamol affects expression ISO Fmo1 (Mus musculus) 6480464 Acetaminophen affects the expression of FMO1 mRNA CTD PMID:17562736 paracetamol increases expression ISO Fmo1 (Mus musculus) 6480464 Acetaminophen results in increased expression of FMO1 mRNA CTD PMID:11264010 parathion increases expression ISO Fmo1 (Mus musculus) 6480464 Parathion results in increased expression of FMO1 mRNA CTD PMID:34813904 pentachlorophenol increases expression ISO Fmo1 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of FMO1 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid increases expression ISO Fmo1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of FMO1 mRNA CTD PMID:37995155 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of FMO1 mRNA and perfluorooctanoic acid results in decreased expression of FMO1 protein CTD PMID:19162173 and PMID:34958885 perfluorooctanoic acid decreases expression ISO FMO1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of FMO1 mRNA CTD PMID:36326898 phenobarbital increases expression ISO Fmo1 (Mus musculus) 6480464 Phenobarbital results in increased expression of FMO1 mRNA CTD PMID:19482888 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FMO1 mRNA and [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of FMO1 promoter CTD PMID:25374375 phenobarbital multiple interactions ISO Fmo1 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FMO1 mRNA] CTD PMID:19482888 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of FMO1 mRNA CTD PMID:19162173 phenytoin multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA CTD PMID:21224054 phlorizin decreases expression ISO Fmo1 (Mus musculus) 6480464 Phlorhizin results in decreased expression of FMO1 mRNA CTD PMID:22538082 phosgene affects expression ISO Fmo1 (Mus musculus) 6480464 Phosgene affects the expression of FMO1 mRNA CTD PMID:16300373 piperonyl butoxide decreases expression EXP 6480464 Piperonyl Butoxide results in decreased expression of FMO1 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO Fmo1 (Mus musculus) 6480464 pirinixic acid results in increased expression of FMO1 mRNA CTD PMID:15375163 more ... pirinixic acid decreases expression ISO Fmo1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of FMO1 mRNA CTD PMID:25270620 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of FMO1 mRNA CTD PMID:19162173 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of FMO1 mRNA CTD PMID:19483382 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of FMO1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO Fmo1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of FMO1 mRNA CTD PMID:27413110 and PMID:28903501 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of FMO1 mRNA CTD PMID:22431067 pyrimidin-2-amine affects binding EXP 6480464 2-aminopyrimidine analog binds to FMO1 protein CTD PMID:19317514 quercetin multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in decreased expression of FMO1 mRNA CTD PMID:17639512 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1 mRNA] and resveratrol inhibits the reaction [Estradiol results in decreased expression of FMO1] CTD PMID:24894866 rifampicin multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO1 mRNA CTD PMID:21224054 rotenone increases expression EXP 6480464 Rotenone results in increased expression of FMO1 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO FMO1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium chloride increases expression EXP 6480464 Sodium Chloride results in increased expression of FMO1 mRNA and Sodium Chloride results in increased expression of FMO1 protein CTD PMID:19429252 sodium dichromate decreases expression ISO Fmo1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of FMO1 mRNA CTD PMID:22155349 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of FMO1 mRNA CTD PMID:25993096 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of FMO1 mRNA CTD PMID:12325037 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of FMO1 mRNA CTD PMID:30047161 Sunset Yellow FCF multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of FMO1 mRNA CTD PMID:33819548 tamoxifen affects expression ISO Fmo1 (Mus musculus) 6480464 Tamoxifen affects the expression of FMO1 mRNA CTD PMID:17555576 tartrazine multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of FMO1 mRNA CTD PMID:33819548 tert-butyl hydroperoxide decreases expression ISO FMO1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA CTD PMID:12419474 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of FMO1 mRNA CTD PMID:21515302 testosterone decreases expression ISO Fmo1 (Mus musculus) 6480464 Testosterone results in decreased expression of FMO1 mRNA CTD PMID:20600201 and PMID:21669218 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of FMO1 mRNA CTD PMID:12734012 and PMID:15963342 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FMO1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO Fmo1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of FMO1 mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FMO1 mRNA and Carbon Tetrachloride results in decreased expression of FMO1 protein CTD PMID:12629582 more ... tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of FMO1 mRNA CTD PMID:17522070 tetraphene multiple interactions ISO Fmo1 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FMO1 mRNA CTD PMID:27858113 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of FMO1 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of FMO1 mRNA CTD PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of FMO1 mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO Fmo1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of FMO1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO Fmo1 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMO1 mRNA CTD PMID:29950665 topotecan increases expression EXP 6480464 Topotecan results in increased expression of FMO1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of FMO1 mRNA CTD PMID:25729387 tremolite asbestos decreases expression ISO Fmo1 (Mus musculus) 6480464 tremolite results in decreased expression of FMO1 mRNA CTD PMID:29279043 trichostatin A increases expression ISO FMO1 (Homo sapiens) 6480464 trichostatin A results in increased expression of FMO1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO FMO1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA CTD PMID:27188386 triclosan increases expression ISO FMO1 (Homo sapiens) 6480464 Triclosan results in increased expression of FMO1 mRNA CTD PMID:30510588 triclosan multiple interactions ISO FMO1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of FMO1 mRNA CTD PMID:33819548 trimellitic anhydride decreases expression ISO Fmo1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of FMO1 mRNA CTD PMID:19042947 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of FMO1 mRNA CTD PMID:30589522 triptonide affects expression ISO Fmo1 (Mus musculus) 6480464 triptonide affects the expression of FMO1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO FMO1 (Homo sapiens) 6480464 troglitazone results in decreased expression of FMO1 mRNA CTD PMID:19631733 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FMO1 mRNA CTD PMID:21515302 troglitazone increases expression ISO FMO1 (Homo sapiens) 6480464 troglitazone results in increased expression of FMO1 mRNA CTD PMID:19631733 tunicamycin decreases expression ISO Fmo1 (Mus musculus) 6480464 Tunicamycin results in decreased expression of FMO1 mRNA CTD PMID:17127020 usnic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of FMO1 mRNA CTD PMID:22777745 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of FMO1 mRNA CTD PMID:24136188 valproic acid decreases expression ISO FMO1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of FMO1 mRNA CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of FMO1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO FMO1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FMO1 mRNA CTD PMID:27188386 valproic acid increases expression ISO FMO1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of FMO1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO Fmo1 (Mus musculus) 6480464 Valproic Acid affects the expression of FMO1 mRNA CTD PMID:17963808 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of FMO1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FMO1 mRNA CTD PMID:22570695 zinc pyrithione increases expression ISO FMO1 (Homo sapiens) 6480464 pyrithione zinc results in increased expression of FMO1 mRNA CTD PMID:21424779